Furthermore, this study aims to determine the correlation between the PD-L1 tumor cell expression and clinicopathological prognostic factors, lymphocyte density displaying PD-1, CD4, and CD8 expression in the tumor microenvironment in ccRCC series. This evidence concerns the gene PDCD1 and neoplasm.